Arsenic-induced carcinogenesissoxidative stress as a possible mode of action and future research needs for more biologically based risk assessment

Chemical Research in Toxicology

Volumn 23, Issue 2, 2010, Pages 327-335

  Kitchin, Kirk T ^a   Conolly, Rory ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; 8 HYDROXYDEOXYGUANOSINE; ANTIOXIDANT; ARSENIC; GROWTH FACTOR; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; THIOREDOXIN REDUCTASE; TRANSCRIPTION FACTOR; CARCINOGEN;

BLADDER CANCER; CANCER RISK; CARCINOGENICITY; CELL PROLIFERATION; CHEMICAL CARCINOGENESIS; CHROMOSOME DAMAGE; CYTOTOXICITY; DNA DAMAGE; DNA REPAIR; DOSE RESPONSE; GENE MUTATION; HUMAN; KIDNEY CANCER; LIVER CANCER; LUNG CANCER; MEDICAL RESEARCH; MODEL; NONHUMAN; OXIDATIVE STRESS; REVIEW; RISK ASSESSMENT; SKIN CANCER; TOXICOKINETICS; BIOLOGICAL MODEL; CHEMICALLY INDUCED DISORDER; NEOPLASM;

ANIMALIA;

ARSENIC; CARCINOGENS; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; OXIDATIVE STRESS; RISK ASSESSMENT;

EID: 77049126844     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/tx900343d     Document Type: Review

References (61)

1. National Research Council (1999) Health Effects of Arsenic, pp 83- 149, National Academy Press, Washington, DC.
2. Hutchinson, J. (1887) Arsenic cancer. Br. Med. J. 2, 1280-1281.
3. Tseng, W. P., Chu, H. M., How, S. H., Fong, J. M., Lin, C. S., and Yeh, S. (1968) Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J. Natl. Cancer Inst. 40, 453-463.
4. Wu, M. M., Kuo, T. L., Hwang, Y. H., and Chen, C. J. (1989) Doseresponse relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am. J. Epidemiol. 130, 1123-1132.
5. Guo, H. R., Chiang, H. S., Hu, H., Lipsitz, S. R., and Monson, R. R. (1997) Arsenic in drinking water and incidence of urinary cancers. Epidemiology 8, 545-550.
6. Smith, A. H., Goycolea, M., Haque, R., and Biggs, M. L. (1998) Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water. Am. J. Epidemiol. 147, 660-669.
7. Hopenhayn-Rich, C., Biggs, M. L., Fuchs, A., Bergoglio, R., Tello, E. E., Nicolli, H., and Smith, A. H. (1996) Bladder cancer mortality associated with arsenic in drinking water in Argentina. Epidemiology (Cambridge, MA) 7, 117-124.
8. Hopenhayn-Rich, C., Biggs, M. L., and Smith, A. H. (1998) Lung and kidney cancer mortality associated with arsenic in drinking water in Cordoba, Argentina. Int. J. Epidemiol. 27, 561-569.
9. Wei, M., Wanibuchi, H., Morimura, K., Iwai, S., Yoshida, K., Endo, G., Nakae, D., and Fukushima, S. (2002) Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors. Carcinogenesis 23, 1387-1397.
10. Chen, Y., Megosh, L. C., Gilmour, S. K., Sawicki, J. A., and O'Brien, T. G. (2000) K6/ODC transgenic mice as a sensitive model for carcinogen identification. Toxicol. Lett. 116, 27-35.
11. Hayashi, H., Kanisawa, M., Yamanaka, K., Ito, T., Udaka, N., Ohji, H., Okudela, K., Okada, S., and Kitamura, H. (1998) Dimethylarsenic acid, a main metabolite of inorganic arsenics, has tumorigenicity and progression effects in the pulmonary tumors of A/J mice. Cancer Lett. 125, 83-88.
12. Shen, J., Wanibuchi, H., Salim, E. I., Wei, M., Kinoshita, A., Yoshida, K., Endo, G., and Fukushima, S. (2003) Liver tumorigenicity of trimethylarsine oxide in male Fischer 344 ratssAssociation with oxidative DNA damage and enhanced cell proliferation. Carcinogenesis 24, 1827-1835.
13. Chen, Y., O'Brien, T. G., Del Razo, L. M., Thomas, D. J., and Kitchin, K. T. (2008) Tissue levels of arsenicals and skin tumor response following administration of monomethylarsonous acid and arsenite to K6/ODC mice. J. Environ. Pathol., Toxicol. Oncol. 27, 43-52.
14. Waalkes, M. P., Ward, J. M., Liu, J., and Diwan, B. A. (2003) Transplacental carcinogenicity of inorganic arsenic in the drinking water: Induction of hepatic, ovarian, pulmonary, and adrenal tumors in mice. Toxicol. Appl. Pharmacol. 186, 7-17.
15. Kitchin, K. T., and Wallace, K. (2008) The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. J. Inorg. Biochem. 102, 532-539.
16. Mann, S., Droz, P. O., and Vahter, M. (1996) A physiologically based pharmacokinetic model for arsenic exposure. I. Development in hamsters and rabbits. Toxicol. Appl. Pharmacol. 137, 8-22.
17. Mann, S., Droz, P. O., and Vahter, M. (1996) A physiologically based pharmacokinetic model for arsenic exposure. II. Validation and application in humans. Toxicol. Appl. Pharmacol. 140, 471-486.
18. Gentry, P. R., Covington, T. R., Mann, S., Shipp, A. M., Yager, J. W., and Clewell, H. J., 3rd. (2004) Physiologically based pharmacokinetic modeling of arsenic in the mouse. J. Toxicol. Environ. Health 67, 43-71.
19. Evans, M., Dowd, S., Kenyon, E., Hughes, M., and El-Masri, H. (2008) A physiologically based pharmacokinetic (PBPK) model for intravenous and ingested dimethylarsinic acid (DMA(V)) in mice. Toxicol. Sci. 104, 250-260.
20. El-Masri, H. A., and Kenyon, E. M. (2008) Development of a human physiologically based pharmacokinetic (PBPK) model for inorganic arsenic and its mono- and di-methylated metabolites. J. Pharmacokinet. Pharmacodyn. 35, 31-68.
21. Lau, C., Mole, M. L., Copeland, M. F., Rogers, J. M., Kavlock, R. J., Shuey, D. L., Cameron, A. M., Ellis, D. H., Logsdon, T. R., Merriman, J., and Setzer, R. W. (2001) Toward a biologically based dose-response model for developmental toxicity of 5-fluorouracil in the rat: Acquisition of experimental data. Toxicol. Sci. 59, 37-48.
22. Setzer, R. W., Lau, C., Mole, M. L., Copeland, M. F., Rogers, J. M., and Kavlock, R. J. (2001) Toward a biologically based dose-response model for developmental toxicity of 5-fluorouracil in the rat: A mathematical construct. Toxicol. Sci. 59, 49-58.
23. McLanahan, E. D., Andersen, M. E., and Fisher, J. W. (2008) A biologically based dose-response model for dietary iodide and the hypothalamic-pituitary-thyroid axis in the adult rat: evaluation of iodide deficiency. Toxicol. Sci. 102, 241-253.
24. Conolly, R. B., Kimbell, J. S., Janszen, D., Schlosser, P. M., Kalisak, D., Preston, J., and Miller, F. J. (2004) Human respiratory tract cancer risks of inhaled formaldehyde: dose-response predictions derived from biologically-motivated computational modeling of a combined rodent and human dataset. Toxicol. Sci. 82, 279-296.
25. Cohen, S. M., Meek, M. E., Klaunig, J. E., Patton, D. E., and Fenner- Crisp, P. A. (2003) The human relevance of information on carcinogenic modes of action: overview. Crit. Rev. Toxicol. 33, 581-589.
26. Cohen, S. M., Klaunig, J., Meek, M. E., Hill, R. N., Pastoor, T., Lehman-McKeeman, L., Bucher, J., Longfellow, D. G., Seed, J., Dellarco, V., Fenner-Crisp, P., and Patton, D. (2004) Evaluating the human relevance of chemically induced animal tumors. Toxicol. Sci. 78, 181-186.
27. Rice, J. M. (2004) On the application of data on mode of action to carcinogenic risk assessment. Toxicol. Sci. 78, 175-177.
28. Dellarco, V. L., and Baetcke, K. (2005) A risk assessment perspective: application of mode of action and human relevance frameworks to the analysis of rodent tumor data. Toxicol. Sci. 86, 1-3.
29. Andrewes, P., Kitchin, K. T., and Wallace, K. (2003) Dimethylarsine and trimethylarsine are potent genotoxins in vitro. Chem. Res. Toxicol. 16, 994-1003.
30. Drobna, Z., Naranmandura, H., Kubachka, K. M., Edwards, B. C., Herbin-Davis, K., Styblo, M., Le, X. C., Creed, J. T., Maeda, N., Hughes, M. F., and Thomas, D. J. (2009) Disruption of the arsenic (+3 oxidation state) methyltransferase gene in the mouse alters the phenotype for methylation of arsenic and affects distribution and retention of orally administered arsenate. Chem. Res. Toxicol. 22, 1713-1720.
31. Thomas, D. J., Styblo, M., and Lin, S. (2001) The cellular metabolism and systemic toxicity of arsenic. Toxicol. Appl. Pharmacol. 176, 127-144.
32. Healy, S. M., Zakharyan, R. A., and Aposhian, H. V. (1997) Enzymatic methylation of arsenic compounds: IV. In vitro and in vivo deficiency of the methylation of arsenite and monomethylarsonic acid in the guinea pig. Mutat. Res. 386, 229-239.
33. Styblo, M., Del Razo, L. M., Vega, L., Germolec, D. R., LeCluyse, E. L., Hamilton, G. A., Reed, W., Wang, C., Cullen, W. R., and Thomas, D. J. (2000) Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch. Toxicol. 74, 289-299.
34. Hughes, M. F., Del Razo, L. M., and Kenyon, E. M. (2000) Dosedependent effects on tissue distribution and metabolism of dimethylarsinic acid in the mouse after intravenous administration. Toxicology 143, 155-166.
35. Kitchin, K. T. (2001) Recent advances in arsenic carcinogenesis: Modes of action, animal model systems, and methylated arsenic metabolites. Toxicol. Appl. Pharmacol. 172, 249-261.
36. Hughes, M., and Kitchin, K. (2006) Arsenic, oxidative stress and carcinogenesis. In Oxidative Stress, Disease and Cancer (Singh, K., Ed.) pp 825-850, Imperial Collegge Press, London.
37. Kitchin, K. T., and Ahmad, S. (2003) Oxidative stress as a possible mode of action for arsenic carcinogenesis. Toxicol. Lett. 137, 3-13.
38. Waalkes, M. P., Liu, J., Chen, H., Xie, Y., Achanzar, W. E., Zhou, Y. S., Cheng, M. L., and Diwan, B. A. (2004) Estrogen signaling in livers of male mice with hepatocellular carcinoma induced by exposure to arsenic in utero. J. Natl. Cancer Inst. 96, 466-474.
39. Kenyon, E. M., Hughes, M. F., Adair, B. M., Highfill, J. H., Crecelius, E. A., Clewell, H. J., and Yager, J. W. (2008) Tissue distribution and urinary excretion of inorganic arsenic and its methylated metabolites in C57BL6 mice following subchronic exposure to arsenate in drinking water. Toxicol. Appl. Pharmacol. 232, 448-455.
40. Ahmad, S., Kitchin, K. T., and Cullen, W. R. (2002) Plasmid DNA damage caused by methylated arsenicals, ascorbic acid and human liver ferritin. Toxicol. Lett. 133, 47-57.
41. Clewell, H. J., Thomas, R. S., Gentry, P. R., Crump, K. S., Kenyon, E. M., El-Masri, H. A., and Yager, J. W. (2007) Research toward the development of a biologically based dose response assessment for inorganic arsenic carcinogenicity: A progress report. Toxicol. Appl. Pharmacol. 222, 388-398.
42. Valko, M., Morris, H., and Cronin, M. T. (2005) Metals, toxicity and oxidative stress. Curr. Med. Chem. 12, 1161-1208.
43. Valko, M., Rhodes, C. J., Moncol, J., Izakovic, M., and Mazur, M. (2006) Free radicals, metals and antioxidants in oxidative stressinduced cancer. Chem.-Biol. Interact. 160, 1-40.
44. Chilakapati, J., Wallace, K., Thomas, D. J., Moore, T., Ren, H., Ward, W. O., and Kitchin, K. T. (2009) Effects of arsenite in drinking water on mouse lung in a 30 day exposure. The Toxicologist, p 329, Abstract Number 1587.
45. Santra, A., Maiti, A., Das, S., Lahiri, S., Charkaborty, S. K., and Mazumder, D. N. (2000) Hepatic damage caused by chronic arsenic toxicity in experimental animals. J. Toxicol. Clin. Toxicol. 38, 395-405.
46. Cullen, W. R., McBride, B. C., and Reglinski, J. (1984) The reduction of trimethylarsine oxide to trimethylarsine by thiols: A mechanistic model for the biological reduction of arsenicals. J. Inorg. Biochem. 21, 45-60.
47. Yamanaka, K., Mizol, M., Kato, K., Hasegawa, A., Nakano, M., and Okada, S. (2001) Oral administration of dimethylarsinic acid, a main metabolite of inorganic arsenic, in mice promotes skin tumorigenesis initiated by dimethylbenz(a)anthracene with or without ultraviolet B as a promoter. Biol. Pharm. Bull. 24, 510-514.
48. Kligerman, A. D., Doerr, C. L., Tennant, A. H., Harrington-Brock, K., Allen, J. W., Winkfield, E., Poorman-Allen, P., Kundu, B., Funasaka, K., Roop, B. C., Mass, M. J., and DeMarini, D. M. (2003) Methylated trivalent arsenicals as candidate ultimate genotoxic forms of arsenic: Induction of chromosomal mutations but not gene mutations. Environ. Mol. Mutagen. 42, 192-205.
49. Nesnow, S., Roop, B. C., Lambert, G., Kadiiska, M., Mason, R. P., Cullen, W. R., and Mass, M. J. (2002) DNA damage induced by methylated trivalent arsenicals is mediated by reactive oxygen species. Chem. Res. Toxicol. 15, 1627-1634.
50. Moustacchi, E. (2000) DNA damage and repair: consequences on doseresponses. Mutat. Res. 464, 35-40.
51. Hakem, R. (2008) DNA-damage repair; the good, the bad, and the ugly. EMBO J. 27, 589-605.
52. Wise, S. S., Holmes, A. L., and Wise, J. P., Sr. (2008) Hexavalent chromium-induced DNA damage and repair mechanisms. Rev. Environ. Health 23, 39-57.
53. Hartwig, A., Blessing, H., Schwerdtle, T., and Walter, I. (2003) Modulation of DNA repair processes by arsenic and selenium compounds. Toxicology 193, 161-169.
54. Jones, S., Zhang, X., Parsons, D. W., Lin, J. C., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., Hong, S. M., Fu, B., Lin, M. T., Calhoun, E. S., Kamiyama, M., Walter, K., Nikolskaya, T., Nikolsky, Y., Hartigan, J., Smith, D. R., Hidalgo, M., Leach, S. D., Klein, A. P., Jaffee, E. M., Goggins, M., Maitra, A., Iacobuzio-Donahue, C., Eshleman, J. R., Kern, S. E., Hruban, R. H., Karchin, R., Papadopoulos, N., Parmigiani, G., Vogelstein, B., Velculescu, V. E., and Kinzler, K. W. (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321, 1801-1806.
55. Parsons, D. W., Jones, S., Zhang, X., Lin, J. C., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I. M., Gallia, G. L., Olivi, A., McLendon, R., Rasheed, B. A., Keir, S., Nikolskaya, T., Nikolsky, Y., Busam, D. A., Tekleab, H., Diaz, L. A., Jr., Hartigan, J., Smith, D. R., Strausberg, R. L., Marie, S. K., Shinjo, S. M., Yan, H., Riggins, G. J., Bigner, D. D., Karchin, R., Papadopoulos, N., Parmigiani, G., Vogelstein, B., Velculescu, V. E., and Kinzler, K. W. (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321, 1807-1812.
56. Moolgavkar, S. H. (1988) Biologically motivated two-stage model for cancer risk assessment. Toxicol. Lett. 43, 139-150.
57. Moolgavkar, S. H. (1994) Biological models of carcinogenesis and quantitative cancer risk assessment. Risk Anal. 14, 879-882.
58. Ling, M. P., and Liao, C. M. (2009) A human PBPK/PD model to assess arsenic exposure risk through farmed tilapia consumption. Bull. Environ. Contam. Toxicol. 83, 108-114.
59. Kinoshita, A., Wanibuchi, H., Morimura, K., Wei, M., Nakae, D., Arai, T., Minowa, O., Noda, T., Nishimura, S., and Fukushima, S. (2007) Carcinogenicity of dimethylarsinic acid in Ogg1-deficient mice. Cancer Sci. 98, 803-814.
60. Challenger, F. (1945) Biological methylation. Chem. Rev. 36, 315-361.
61. Kitchin, K. (2010) Arsenic's interactions with macromolecules and its relationship to carcinogenesis. In Biological Chemistry of Arsenic, Antimony, and Bismuth (Sun, Hongzhe, Ed.) Wiley-Blackwell, United Kingdom.